Category: Reagents

Filter By
Hydroxy Bosentan Hydroxy Bosentan

Hydroxy Bosentan

Reference: 22366-5
€0.00 (tax incl.)
A metabolite of bosentan; produced by CYP3A4 and CYP2C9,
Hydroxy Bosentan Hydroxy Bosentan

Hydroxy Bosentan

Reference: 22366-500
€0.00 (tax incl.)
A metabolite of bosentan; produced by CYP3A4 and CYP2C9,
Bortezomib-d15 Bortezomib-d15

Bortezomib-d15

Reference: 22367-1
€0.00 (tax incl.)
An internal standard for the quantification of bortezomib by GC- or LC-MS
Bortezomib-d15 Bortezomib-d15

Bortezomib-d15

Reference: 22367-500
€0.00 (tax incl.)
An internal standard for the quantification of bortezomib by GC- or LC-MS
Empagliflozin-d4 Empagliflozin-d4

Empagliflozin-d4

Reference: 22369-1
€0.00 (tax incl.)
An internal standard for the quantification of empagliflozin by GC- or LC-MS,
Empagliflozin-d4 Empagliflozin-d4

Empagliflozin-d4

Reference: 22369-500
€0.00 (tax incl.)
An internal standard for the quantification of empagliflozin by GC- or LC-MS,
Lenalidomide-d5 Lenalidomide-d5

Lenalidomide-d5

Reference: 22370-1
€0.00 (tax incl.)
An internal standard for the quantification of lenalidomide by GC- or LC-MS
Lenalidomide-d5 Lenalidomide-d5

Lenalidomide-d5

Reference: 22370-500
€0.00 (tax incl.)
An internal standard for the quantification of lenalidomide by GC- or LC-MS
Temozolomide-d3 Temozolomide-d3

Temozolomide-d3

Reference: 22372-1
€0.00 (tax incl.)
An internal standard for the quantification of temozolomide by GC- or LC-MS,
Temozolomide-d3 Temozolomide-d3

Temozolomide-d3

Reference: 22372-5
€0.00 (tax incl.)
An internal standard for the quantification of temozolomide by GC- or LC-MS,
Temozolomide-d3 Temozolomide-d3

Temozolomide-d3

Reference: 22372-500
€0.00 (tax incl.)
An internal standard for the quantification of temozolomide by GC- or LC-MS,
Vildagliptin-d7 Vildagliptin-d7

Vildagliptin-d7

Reference: 22373-1
€0.00 (tax incl.)
An internal standard for the quantification of vildagliptin by GC- or LC-MS
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-S
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
Vildagliptin-d7 Vildagliptin-d7

Vildagliptin-d7

Reference: 22373-500
€0.00 (tax incl.)
An internal standard for the quantification of vildagliptin by GC- or LC-MS
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-5.1
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-5
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-10
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
Posaconazole-d5 Posaconazole-d5

Posaconazole-d5

Reference: 22376-1
€0.00 (tax incl.)
An internal standard for the quantification of posaconazole by GC- or LC-MS
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-50
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
Posaconazole-d5 Posaconazole-d5

Posaconazole-d5

Reference: 22376-500
€0.00 (tax incl.)
An internal standard for the quantification of posaconazole by GC- or LC-MS
GDC-0068 (RG7440) GDC-0068 (RG7440)

GDC-0068 (RG7440)

Reference: A3006-100
€0.00 (tax incl.)
Pan-AKT inhibitor,highly selective
Bicalutamide-d4 Bicalutamide-d4

Bicalutamide-d4

Reference: 22377-1
€0.00 (tax incl.)
An internal standard for the quantification of bicalutamide by GC- or LC-MS,
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-S
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Bicalutamide-d4 Bicalutamide-d4

Bicalutamide-d4

Reference: 22377-500
€0.00 (tax incl.)
An internal standard for the quantification of bicalutamide by GC- or LC-MS,
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-5
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Methotrexate-d3 Methotrexate-d3

Methotrexate-d3

Reference: 22378-1
€0.00 (tax incl.)
An internal standard for the quantification of methotrexate by GC- or LC-MS
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-10
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Methotrexate-d3 Methotrexate-d3

Methotrexate-d3

Reference: 22378-10
€0.00 (tax incl.)
An internal standard for the quantification of methotrexate by GC- or LC-MS
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-5.1
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Methotrexate-d3 Methotrexate-d3

Methotrexate-d3

Reference: 22378-5
€0.00 (tax incl.)
An internal standard for the quantification of methotrexate by GC- or LC-MS
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-50
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Methotrexate-d3 Methotrexate-d3

Methotrexate-d3

Reference: 22378-500
€0.00 (tax incl.)
An internal standard for the quantification of methotrexate by GC- or LC-MS
ABT-263 (Navitoclax) ABT-263 (Navitoclax)

ABT-263 (Navitoclax)

Reference: A3007-100
€0.00 (tax incl.)
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
Propranolol β-D-Glucuronide (sodium salt) Propranolol β-D-Glucuronide (sodium salt)

Propranolol β-D-Glucuronide (sodium salt)

Reference: 22382-1
€0.00 (tax incl.)
A major metabolite of propranolol; propranolol clearance through this pathway is higher in men than in women by approximately 50%; has been found in environmental water samples
Propranolol β-D-Glucuronide (sodium salt) Propranolol β-D-Glucuronide (sodium salt)

Propranolol β-D-Glucuronide (sodium salt)

Reference: 22382-500
€0.00 (tax incl.)
A major metabolite of propranolol; propranolol clearance through this pathway is higher in men than in women by approximately 50%; has been found in environmental water samples
Sphingosine-1-phosphate (d17:1) Sphingosine-1-phosphate (d17:1)

Sphingosine-1-phosphate (d17:1)

Reference: 22498-1
€0.00 (tax incl.)
A synthetic sphingolipid; has been used as an internal standard for the quantification of S1P (d18:1) in plasma and tissue samples
Sorafenib Sorafenib

Sorafenib

Reference: A3009-S
€0.00 (tax incl.)
Raf kinases and tyrosine kinases inhibitor
Sphingosine-1-phosphate (d17:1) Sphingosine-1-phosphate (d17:1)

Sphingosine-1-phosphate (d17:1)

Reference: 22498-5
€0.00 (tax incl.)
A synthetic sphingolipid; has been used as an internal standard for the quantification of S1P (d18:1) in plasma and tissue samples
Sorafenib Sorafenib

Sorafenib

Reference: A3009-5.1
€0.00 (tax incl.)
Raf kinases and tyrosine kinases inhibitor
Sphingosine-1-phosphate (d17:1) Sphingosine-1-phosphate (d17:1)

Sphingosine-1-phosphate (d17:1)

Reference: 22498-500
€0.00 (tax incl.)
A synthetic sphingolipid; has been used as an internal standard for the quantification of S1P (d18:1) in plasma and tissue samples
Sorafenib Sorafenib

Sorafenib

Reference: A3009-20
€0.00 (tax incl.)
Raf kinases and tyrosine kinases inhibitor
Sphinganine (d17:0) Sphinganine (d17:0)

Sphinganine (d17:0)

Reference: 22510-1
€0.00 (tax incl.)
A bioactive sphingolipid; inhibits the growth of C. glabrata and C. albicans (MFCs = 0.5 μg/ml for both); used as an internal standard in the analysis of sphingoid compounds by chromatographic or spectrometric methods,
Sorafenib Sorafenib

Sorafenib

Reference: A3009-50
€0.00 (tax incl.)
Raf kinases and tyrosine kinases inhibitor

Menu

Settings

Please sign in first.

Sign in